Takara Holdings Inc (TKHIF)
7.10
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.386B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -- |
| Valuation | |
| PE Ratio | 12.74 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.6062 |
| Price to Book Value | 0.819 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.1927 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1768 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Takara Holdings Inc operates three businesses: Alcoholic Beverages and Seasonings, Biomedical, and Health Foods. Roughly 80% of the company's sales come from Japan. The Alcoholic Beverages and Seasonings business, which manufactures shochu, sake, light-alcohol refreshers, seasonings, and raw alcohol, generates the vast majority of the company's revenue. Most remaining revenue comes from the biomedical business, which primarily manufactures and sells reagents and other instruments for biomedical researchers but also provides contract research services and develops health food ingredients. Takara's foods business develops and sells health food products that are largely based on seaweed, algae, and herbs. |
| URL | http://www.takara.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Consumer Staples |
| Industry | Beverages |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Mar. 28, 2025 |
| Last Ex-Dividend Date | Mar. 28, 2024 |
Ratings
Profile
| Takara Holdings Inc operates three businesses: Alcoholic Beverages and Seasonings, Biomedical, and Health Foods. Roughly 80% of the company's sales come from Japan. The Alcoholic Beverages and Seasonings business, which manufactures shochu, sake, light-alcohol refreshers, seasonings, and raw alcohol, generates the vast majority of the company's revenue. Most remaining revenue comes from the biomedical business, which primarily manufactures and sells reagents and other instruments for biomedical researchers but also provides contract research services and develops health food ingredients. Takara's foods business develops and sells health food products that are largely based on seaweed, algae, and herbs. |
| URL | http://www.takara.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | Consumer Staples |
| Industry | Beverages |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | Mar. 28, 2025 |
| Last Ex-Dividend Date | Mar. 28, 2024 |